62,000 estimated cases of Leukemia in 2019 in the U.S.- American Cancer Society

The market report titled ‘Global Leukemia Market – Size, Share and Forecast (2019-2026)’ by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.

Leukemia occurs most often in adults older over the age of 55. Among cancers, the incidence rate of Leukemia is highest among children younger than 15. According to ACS, around 3 out of 4, childhood leukemias are Acute Lymphocytic Leukemia.
Leukemia Market- Segmentation

The global leukemia market can be segmented by

Disease type as Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia.
Over the period of forecast(2019-2016) incidence of Acute Lymphocytic Leukemia is expected to grow, leading to growth in their therapeutics market.

Treatment type as Medication, Surgery, Chemotherapy, Biological Therapy, Immunotherapy, Radiation Therapy, Targeted Therapy, and Stem Cell Transplantation.
Chemotherapy is the dominant treatment for most people with leukemia.

Leukemia Market- Regional Distribution

North America is expected to dominate the market in the forecast period followed by Europe. This is due to healthcare access, favorable reimbursement policies, advanced healthcare infrastructure and high disease prevalence.

Asia Pacific is anticipated to have the highest growth rate in the forecast period due to the development of healthcare infrastructure in China and India. Plus, investment in R&D activities is projected to accelerate the growth of the leukemia market in the region.
In the southern hemisphere, the World Health Organization (WHO) data indicates that Australia and New Zealand have the highest regional leukemia rate in the world- about 11.3 per 100,000 population.

Visit the link below to get a free sample market report-
https://www.datamintelligence.com/research-report/leukemia-market/

Listed below are the topics covered in this market research report-
1. Global Leukemia Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Global Leukemia Market – Market Definition and Overview
3. Global Leukemia Market – Executive Summary
3.1. Market Snippet by Disease Type
3.2. Market Snippet by Treatment Type
3.3. Market Snippet by Region
3.4. DataM CLO Scenario
4. Global Leukemia Market – Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in prevalence population
4.1.1.2. Drug launches and robust pipeline
4.1.1.3. Rise in healthcare expenditure
4.1.2. Restraints
4.1.2.1. High costs associated with drug development
4.1.2.2. Adverse side-effects
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Global Leukemia Market – Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Epidemiology
5.4. Pipeline Insights
5.5. Key Companies to Watch
6. Global Leukemia Market – By Disease Type
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
6.3. Market Attractiveness Index, By Disease Type
6.4. Acute Lymphocytic Leukemia
6.4.1. Introduction
6.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.5. Chronic Lymphocytic Leukemia
6.6. Acute Myeloid Leukemia
6.7. Chronic Myeloid Leukemia
7. Global Leukemia Market – By Treatment Type
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
7.3. Market Attractiveness Index, By Treatment Type
7.4. Surgery
7.4.1. Introduction
7.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
7.5. Chemotherapy
7.6. Immunotherapy
7.7. Radiation Therapy
7.8. Targeted Therapy
7.9. Stem Cell Transplantation
8. Global Leukemia Market – By Region
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
8.3. Market Attractiveness Index, By Region
8.4. North America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. U.S.
8.4.5.2. Canada
8.4.5.3. Mexico
8.5. Europe
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.5.5.1. Germany
8.5.5.2. U.K.
8.5.5.3. France
8.5.5.4. Italy
8.5.5.5. Spain
8.5.5.6. Rest of Europe
8.6. South America
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
8.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.6.5.1. Brazil
8.6.5.2. Argentina
8.6.5.3. Rest of South America
8.7. Asia-Pacific
8.7.1. Introduction
8.7.2. Key Region-Specific Dynamics
8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
8.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.7.5.1. China
8.7.5.2. India
8.7.5.3. Japan
8.7.5.4. Australia
8.7.5.5. Rest of Asia Pacific
8.8. Middle East and Africa
8.8.1. Introduction
8.8.2. Key Region-Specific Dynamics
8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
9. Global Market – Competitive Landscape
9.1. Competitive Scenario
9.2. Competitor Leukemia Strategy Analysis
9.3. Comparative Product Portfolio Analysis
9.4. Market Positioning/Share Analysis
9.5. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. AbbVie, Inc. *
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Key Highlights
10.1.4. Financial Overview
10.2. Novartis
10.3. Pfizer
10.4. Bristol-Myers Squibb Company
10.5. Genzyme
10.6. Celgene
10.7. GlaxoSmithKline
10.8. Cephalon
10.9. Eisai
10.10. Teva Pharmaceuticals
10.11. Company XX
10.12. Company XX
11. Global Leukemia Market – Premium Insights
12. Global Leukemia Market – DataM
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us

1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

About DataM Intelligence

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

DMI is currently strengthening its cross-industrial database for sectors including Chemicals, Materials, Agriculture, Healthcare Services, Animal Nutrition, Consumer Goods, Food & Beverages, Industrial Machinery, and Automation among others.

This release was published on openPR.